Nicola Annels

4.3k total citations
57 papers, 3.3k citations indexed

About

Nicola Annels is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Nicola Annels has authored 57 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 29 papers in Oncology and 13 papers in Surgery. Recurrent topics in Nicola Annels's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (12 papers) and Virus-based gene therapy research (11 papers). Nicola Annels is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (12 papers) and Virus-based gene therapy research (11 papers). Nicola Annels collaborates with scholars based in United Kingdom, Netherlands and United States. Nicola Annels's co-authors include Alan B. Rickinson, Alison M. Leese, Gary Middleton, Nancy Gudgeon, Hardev Pandha, Deborah Stocken, Neil Steven, Andrew D. Hislop, Margaret Callan and Linda Tan and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Nicola Annels

54 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Annels United Kingdom 25 2.1k 1.6k 678 472 396 57 3.3k
Joël Plumas France 37 3.7k 1.8× 1.1k 0.7× 634 0.9× 1.2k 2.5× 356 0.9× 104 5.4k
Koji Nagafuji Japan 33 1.2k 0.6× 1.4k 0.9× 780 1.2× 697 1.5× 186 0.5× 181 4.0k
Brigitte Sénéchal United States 18 1.6k 0.8× 2.3k 1.5× 436 0.6× 813 1.7× 228 0.6× 43 4.0k
Laurence Chaperot France 34 3.3k 1.6× 1.1k 0.7× 624 0.9× 1.2k 2.5× 137 0.3× 92 4.9k
J. Alero Thomas United Kingdom 29 1.2k 0.6× 1.1k 0.7× 524 0.8× 440 0.9× 166 0.4× 57 3.0k
O Vérola France 26 775 0.4× 1.2k 0.8× 713 1.1× 465 1.0× 210 0.5× 83 2.7k
Sarah Nikiforow United States 31 1.4k 0.7× 1.8k 1.1× 509 0.8× 463 1.0× 123 0.3× 152 3.4k
Stefania Uccini Italy 27 698 0.3× 936 0.6× 495 0.7× 520 1.1× 253 0.6× 101 2.5k
Joyce D. Fingeroth United States 26 1.2k 0.6× 1.8k 1.2× 1000 1.5× 473 1.0× 266 0.7× 45 3.1k
Kevin Gorski United States 21 2.9k 1.4× 2.4k 1.6× 402 0.6× 1.0k 2.2× 555 1.4× 29 4.9k

Countries citing papers authored by Nicola Annels

Since Specialization
Citations

This map shows the geographic impact of Nicola Annels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Annels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Annels more than expected).

Fields of papers citing papers by Nicola Annels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Annels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Annels. The network helps show where Nicola Annels may publish in the future.

Co-authorship network of co-authors of Nicola Annels

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Annels. A scholar is included among the top collaborators of Nicola Annels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Annels. Nicola Annels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merali, Nabeel, Daniel Liu, Tony Dhillon, et al.. (2023). Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study. International Journal of Molecular Sciences. 24(23). 16888–16888. 5 indexed citations
2.
O’Brien, John, et al.. (2023). O094 Urinary-derived immune cell profiling to predict bladder cancer progression and treatment response. British journal of surgery. 110(Supplement_3).
3.
Annels, Nicola, M. Denyer, Dianne Nicol, et al.. (2023). The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression. Cancer Immunology Immunotherapy. 72(12). 4221–4234. 4 indexed citations
4.
Pandha, Hardev, et al.. (2023). Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21. Methods in molecular biology. 2684. 319–327. 2 indexed citations
5.
Merali, Nabeel, et al.. (2023). Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers. 15(17). 4265–4265. 14 indexed citations
6.
Lythgoe, Mark P., Daniel Liu, Nicola Annels, Jonathan Krell, & Adam E. Frampton. (2021). Gene of the month: lymphocyte-activation gene 3 (LAG-3). Journal of Clinical Pathology. 74(9). 543–547. 31 indexed citations
7.
Annels, Nicola, David Mansfield, Carmen Ballesteros‐Merino, et al.. (2019). Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 25(19). 5818–5831. 97 indexed citations
8.
McGrath, Sophie, Nicola Annels, Thumuluru Kavitha Madhuri, et al.. (2018). Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer. BMC Cancer. 18(1). 943–943. 24 indexed citations
9.
Pandha, Hardev, Nicola Annels, Hugh Mostafid, et al.. (2016). Phase I/II CANON study: oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21. Annals of Oncology. 27. vi361–vi361. 5 indexed citations
10.
Michael, Agnieszka, et al.. (2016). Organotypic slice ovarian cancer model as a platform to test novel therapeutics. Annals of Oncology. 27. vi535–vi535. 1 indexed citations
11.
Simpson, Guy R., András Horváth, Nicola Annels, et al.. (2012). Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British Journal of Cancer. 106(3). 496–507. 28 indexed citations
12.
Morgan, Richard, Michael Bailey, Stephen Langley, et al.. (2011). Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer. Clinical Cancer Research. 17(5). 1090–1098. 85 indexed citations
13.
Middleton, Gary, Nicola Annels, & Hardev Pandha. (2011). Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?. Cancer Immunology Immunotherapy. 61(1). 1–7. 27 indexed citations
14.
Willemze, Annemieke, Tom Révész, Cornelis P. Tensen, et al.. (2010). Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7. Pediatric Blood & Cancer. 55(2). 344–348. 43 indexed citations
15.
Szuhai, Károly, Ronald van Eijk, Manja Hoogeboom, et al.. (2008). No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes and Cancer. 48(3). 239–249. 56 indexed citations
16.
Coury, Fabienne, Nicola Annels, Aymeric Rivollier, et al.. (2007). Langerhans cell histiocytosis reveals a new IL-17A–dependent pathway of dendritic cell fusion. Nature Medicine. 14(1). 81–87. 155 indexed citations
17.
Hislop, Andrew D., Nicola Annels, Nancy Gudgeon, Alison M. Leese, & Alan B. Rickinson. (2002). Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection. The Journal of Experimental Medicine. 195(7). 893–905. 235 indexed citations
18.
Annels, Nicola, John Curnow, Philip Shields, et al.. (2001). Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics. The Journal of Immunology. 167(1). 212–220. 134 indexed citations
19.
Annels, Nicola, Margaret Callan, Linda Tan, & Alan B. Rickinson. (2000). Changing Patterns of Dominant TCR Usage with Maturation of an EBV-Specific Cytotoxic T Cell Response. The Journal of Immunology. 165(9). 4831–4841. 93 indexed citations
20.
Steven, Neil, et al.. (1996). Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.. The Journal of Experimental Medicine. 184(5). 1801–1813. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joël Plumas Breakdown of academic impact, for papers by Koji Nagafuji Breakdown of academic impact, for papers by Brigitte Sénéchal Breakdown of academic impact, for papers by Laurence Chaperot Breakdown of academic impact, for papers by J. Alero Thomas Breakdown of academic impact, for papers by O Vérola Breakdown of academic impact, for papers by Sarah Nikiforow Breakdown of academic impact, for papers by Stefania Uccini Breakdown of academic impact, for papers by Joyce D. Fingeroth Breakdown of academic impact, for papers by Kevin Gorski
Rankless by CCL
2026